Ketotifen
May impair tasks requring mental alertness e.g. driving or operating machinery. History of epilepsy. Pregnancy and lactation. Children <3 yr. Lactation: secreted into breast milk, do not use if breastfeeding
Allergic conjunctivitis, Allergic conditions, Asthma prophylaxis
Acute asthma attack.
N/A
1-10% Weight gain (5.3%),Rash (4%),Respiratory infection (4%),Abdominal pain (1.3%),Increased appetite (1.3%),Epistaxis (1.3%),Puffy eyelid (1.3%),Sleep disturbance (1.3%)
Ketotifen selectively and noncompetitively inhibits the release of mediators from cells involved in hypersensitivity reactions. It is also a mast cell stabiliser.
Reduced platelet count with oral antidiabetics. Potentially Fatal: May potentiate CNS effects of sedatives, hypnotics, antihistamines and alcohol.
Pregnancy Category: safety not established; weigh risk/benefit Lactation: secreted into breast milk, do not use if breastfeeding
Oral Allergic conditions; Asthma prophylaxis Adult: 1 mg bid up to 2 mg bid, as needed. Alternatively, 0.5-1 mg at night for the 1st few days of treatment to minimise drowsiness.
Allergic conditions; Asthma prophylaxis Tablet Child: 6 mth to 3 yr: 0.5 mg bid; >3 yr: 1 mg bid. Syrup: 6 months to 3 years: 0.25 ml / kg body weight, twice daily (Once in the morning & once in the evening).
N/A
Should be taken with food.
The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.